Burgess et al., 1948 - Google Patents
Tocopherols (Vitamin E): Treatment of Lupus Erythematosus; Preliminary ReportBurgess et al., 1948
- Document ID
- 8706027175678711855
- Author
- Burgess J
- Pritchard J
- Publication year
- Publication venue
- Archives of Dermatology and Syphilology
External Links
Snippet
WITH THE knowledge that the administration of tocopherols (vitamin E) had, in sufficient dosage, demonstrated a profound ability to regenerate collagenous tissue in a case of noduloulcerative granuloma with lipoidal deposits, indistinguishable from necrobiosis …
- 239000011732 tocopherol 0 title abstract description 61
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/30—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bayramgürler et al. | Limited benefit of topical calcipotriol in lichen planus treatment: a preliminary study | |
| Burgess et al. | Tocopherols (Vitamin E): Treatment of Lupus Erythematosus; Preliminary Report | |
| CN106924378B (en) | Chinese herbal medicine lipstick for preventing and/or treating chronic cheilitis | |
| JP2003530349A5 (en) | ||
| Levai | A study of certain contributory factors in the development of vitiligo in South Indian patients | |
| Graham et al. | Acquired kinking of the hair associated with etretinate therapy | |
| A. VIGLIOGLIA | Therapeutic evaluation of the oral retinoid Ro 10‐9359 in several non‐psoriatic dermatoses | |
| Viglioglia et al. | Oral retinoids and psoriasis | |
| Hacham-Zadeh et al. | Skin peeling syndrome in a Kurdish family | |
| Halldin et al. | Patients' experiences of pain and pain relief during photodynamic therapy on actinic keratoses: an interview study | |
| LOWE | Optimizing therapy: tazarotene in combination with phototherapy | |
| Schiff et al. | Palmoplantar keratosis acuminata with facial sebaceous hyperplasia | |
| PAPPENFORT et al. | Amodiaquin (Camoquin) in the Treatment of Chronic Discoid Lupus Erythematosus: Preliminary Report, with Special Reference to the Successful Response of Patients Resistant to Other Antimalarial Drugs | |
| ZEISLER | Pityriasis rubra pilaris—familial type | |
| Yesudian et al. | Amphotericin B therapy in dermal leishmanoid | |
| Vorhaus et al. | Clinical experiments with Riboflavin, inositol and calcium Pantothenate | |
| Judge et al. | Disseminated porokeratosis in an infant with craniosynostosis | |
| Goette et al. | Treatment of palmoplantar pustulosis with intralesional triamcinolone injections | |
| Wang et al. | Research Progress of Skin Barrier and Acne | |
| White | Lupus erythematosus. Polyositis. | |
| Fulton Jr | Acne: Its causes and treatments | |
| EP4294518A1 (en) | Remittive effects of tapinarof in the treatment of plaque psoriasis, atopic dermatitis, or radiation dermatitis | |
| Garb | Antimony preparations in the treatment of mycosis fungoides | |
| Ingels et al. | SAN FRANCISCO DERMATOLOGICAL SOCIETY | |
| RU2119350C1 (en) | Agent for treatment of patients with psoriasis |